# Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

> **NCT02447874** · PHASE1,PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 21 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Arginine
- **DRUG:** Arginine (Loading)
- **DRUG:** Arginine (Continuous)

## Key facts

- **NCT ID:** NCT02447874
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-05
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447874, "Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02447874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*